Association between UCP1, UCP2, and UCP3 gene polymorphisms with markers of adiposity in European adolescents: The HELENA study.


Journal

Pediatric obesity
ISSN: 2047-6310
Titre abrégé: Pediatr Obes
Pays: England
ID NLM: 101572033

Informations de publication

Date de publication:
06 2019
Historique:
received: 26 06 2018
revised: 15 11 2018
accepted: 03 12 2018
pubmed: 20 1 2019
medline: 3 8 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

To examine the association between UCP1, UCP2, and UCP3 gene polymorphisms with adiposity markers in European adolescents and to test if there were gene interactions with objectively measured physical activity and adiposity. A cross-sectional study that involves 1.057 European adolescents (12-18 years old) from the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-Sectional Study. A total of 18 polymorphisms in UCP1, UCP2, and UCP3 genes were genotyped. We measured weight, height, waist, and hip circumferences and triceps and subscapular skinfold thickness. Physical activity was objectively measured by accelerometry during 7 days. The C allele of the UCP1 rs6536991 polymorphism was associated with a lower risk of overweight (odds ratio [OR]: T/C + C/C vs T/T) = 0.72; 95% confidence interval [CI]: 0.53-0.98; P = 0.034; false discovery rate [FDR] = 0.048). There was a significant interaction between UCP1 rs2071415 polymorphism and physical activity with waist-to-hip ratio (P = 0.006; FDR = 0.026). Adolescents who did not meet the physical activity recommendations (less than 60 min/day of moderate to vigorous physical activity) and carrying the C/C genotype had higher waist-to-hip ratio (+ 0.067; 95% CI, 0.028-0.106; P = 0.003), while no differences across genotypes were observed in adolescents meeting the recommendations. Two UCP1 polymorphisms were associated with adiposity in European adolescents. Meeting the daily physical activity recommendations may overcome the effect of the UCP1 rs2071415 polymorphism on obesity-related traits.

Identifiants

pubmed: 30659763
doi: 10.1111/ijpo.12504
doi:

Substances chimiques

UCP1 protein, human 0
UCP2 protein, human 0
UCP3 protein, human 0
Uncoupling Protein 1 0
Uncoupling Protein 2 0
Uncoupling Protein 3 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e12504

Informations de copyright

© 2019 World Obesity Federation.

Auteurs

Jose Miguel Pascual-Gamarra (JM)

PROFITH "PROmotingFITness and Healththroughphysicalactivity" researchgroup. Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain.
Department of Physiology, Faculty of Medicine, University of Granada, Granada, Spain.

Diego Salazar-Tortosa (D)

Department of Physiology, Faculty of Medicine, University of Granada, Granada, Spain.
Department of Ecology, Faculty of Sciences, University of Granada, Granada, Spain.

Borja Martinez-Tellez (B)

PROFITH "PROmotingFITness and Healththroughphysicalactivity" researchgroup. Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain.
Department of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Idoia Labayen (I)

Institute for Innovation & Sustainable Development in Food Chain (IS-FOOD), Public University of Navarra, Pamplona, Spain.

Azahara I Rupérez (AI)

Department of Health Sciences, Public University of Navarra, Pamplona, Spain.

Laura Censi (L)

Department of Applied Science of Nutrition, CREA (Council for Agricultural Research and Economics)-Research Center for Food and Nutrition, Rome, Italy.

Yannis Manios (Y)

Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.

Esther Nova (E)

Immunonutrition Group, Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), Madrid, Spain.
Departamento de Metabolismo y Nutrición, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain.

Eva Gesteiro (E)

Departamento de Salud y Rendimiento humano, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain.
ImFine Research Group, Facultad de Ciencias de la Actividad Física y del Deporte-INEF, Universidad Politécnica de Madrid, Madrid, Spain.

Luis A Moreno (LA)

Department of Health Sciences, Public University of Navarra, Pamplona, Spain.

Aline Meirhaeghe (A)

Inserm, Institut Pasteur de Lille, Univ. Lille, UMR1167-RID-AGE-Risk factors and molecular determinants of aging-related diseases, Lille, France.

Jonatan R Ruiz (JR)

PROFITH "PROmotingFITness and Healththroughphysicalactivity" researchgroup. Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain.
Dep. of Biosciences and Nutrition at NOVUM, Karolinska Institutet, Huddinge, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH